Fig. 5
From: Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy
Hybrid nanoparticle-modified targeting ligands promoted trafficking to secondary lymphoid organs. LN targeting and anti-tumor mechanisms of MAN-OVA-IMNPs. (Adapted with permission from [58]. Copyright © 2019, American Chemical Society)